The role of noncoding "junk DNA" in cardiovascular disease.
Vickers
Kasey C
KC
National Institutes of Health, National Heart, Lung, and Blood Institute, Pulmonary and Vascular Medicine Branch, Lipoprotein Metabolism Section, Bethesda, MD 20892-1508, USA.
Palmisano
Brian T
BT
Remaley
Alan T
AT
D000818:Animals; D001808:Blood Vessels / Q000201:enzymology / Q000473:pathology; D002318:Cardiovascular Diseases / Q000201:enzymology / Q000235:genetics* / Q000473:pathology; D049109:Cell Proliferation; D002899:Chromosomes, Human, Pair 9 / Q000235:genetics; D033481:Chromosomes, Mammalian / Q000235:genetics*; D050762:Cyclin-Dependent Kinase Inhibitor p15 / Q000096:biosynthesis / Q000235:genetics*; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000096:biosynthesis / Q000235:genetics*; D021901:DNA, Intergenic / Q000502:physiology*; D005786:Gene Expression Regulation; D056426:Genetic Loci; D020022:Genetic Predisposition to Disease; D006801:Humans; D051379:Mice; D012306:Risk
C417743:Cdkn2a protein, mouse; C493968:Cdkn2b protein, mouse; D050762:Cyclin-Dependent Kinase Inhibitor p15; D019941:Cyclin-Dependent Kinase Inhibitor p16; D021901:DNA, Intergenic